amendment:
  amendment_details: ''
  robustness_impact: false
  robustness_impact_reason: ''
  safety_impact: false
  safety_impact_reason: ''
miscellaneous:
  medical_expert_contact: ''
  sae_reporting_method: ''
  sponsor_signatory: ''
title_page:
  amendment_details: ''
  amendment_identifier: Unavailable
  amendment_scope: Unavailable
  compound_codes: ''
  compound_names: 'Pembroluzumab

    RADVAXTm'
  manufacturer_name_and_address: ''
  medical_expert_contact: ''
  original_protocol: 'Yes'
  regulatory_agency_identifiers: 'UPCC# 40914

    IRB# 821403'
  sae_reporting_method: ''
  sponsor_approval_date: '2015-02-03T00:00:00'
  sponsor_confidentiality: ''
  sponsor_name_and_address: 'University of Pennsylvania

    Address on File.'
  sponsor_signatory: ''
